CN115260037A - Preparation method of 2-methyl-3-nitrobenzyl ether - Google Patents

Preparation method of 2-methyl-3-nitrobenzyl ether Download PDF

Info

Publication number
CN115260037A
CN115260037A CN202210958403.1A CN202210958403A CN115260037A CN 115260037 A CN115260037 A CN 115260037A CN 202210958403 A CN202210958403 A CN 202210958403A CN 115260037 A CN115260037 A CN 115260037A
Authority
CN
China
Prior art keywords
methyl
nitrobenzyl ether
fluoro
preparation
nitrobenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210958403.1A
Other languages
Chinese (zh)
Inventor
王小明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xi'an Tuochao Biotechnology Co ltd
Original Assignee
Xi'an Tuochao Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xi'an Tuochao Biotechnology Co ltd filed Critical Xi'an Tuochao Biotechnology Co ltd
Priority to CN202210958403.1A priority Critical patent/CN115260037A/en
Publication of CN115260037A publication Critical patent/CN115260037A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses a preparation method of 2-methyl-3-nitrobenzyl ether, which comprises the steps of synthesizing 2-methyl-3-nitrobenzyl ether by taking 3-fluoro-2-methyl nitrobenzene as a raw material, dimethyl sulfoxide as a solvent, methanol as an etherification reagent and anhydrous potassium carbonate as alkali, reacting for 24 hours, extracting a reaction solution by using an organic solvent, washing with water, drying, concentrating to remove the solvent, and distilling to obtain solid 2-methyl-3-nitrobenzyl ether. The invention takes 3-fluoro-2-methyl nitrobenzene as raw material to obtain a target product through nucleophilic substitution reaction of methanol. The reaction raw materials are easy to obtain, the route is short, and the yield is high.

Description

Preparation method of 2-methyl-3-nitrobenzyl ether
Technical Field
The invention relates to the field of medicines, and in particular relates to a preparation method of 2-methyl-3-nitrobenzyl ether.
Background
2-methyl-3-nitrobenzyl ether is an important medical intermediate. Is mainly applied to the synthesis of pharmaceutical raw materials. At present, a world patent report (WO 2011/69951) uses 2, 6-dinitrotoluene for selective reduction and diazotization to prepare 2-methyl-3-nitrophenol, and finally, the 2-methyl-3-nitrophenol is generated by etherification reaction with methyl iodide, the three-step reaction is realized, the route has dangerous raw materials, expensive auxiliary materials and long route; CN112552224.2021, which uses expensive catalyst Pd complex, reports that 2-methyl-nitrochlorobenzene is used to prepare products through Pd catalyzed reaction; in addition to the methods, no other methods are reported at present, so that a method for preparing 2-methyl-3-nitrobenzyl ether with easily available raw materials, short route and high yield is lacking at present.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a preparation method of 2-methyl-3-nitrobenzyl ether, which has the advantages of easily obtained raw materials, short route and high yield.
In order to solve the above technical problem, the present invention provides a first technical solution as follows:
the invention relates to a preparation method of 2-methyl-3-nitrobenzyl ether, which comprises the following steps:
the first step, the synthesis of 2-methyl-3-nitrobenzyl ether takes 3-fluoro-2-methyl nitrobenzene as a raw material, dimethyl sulfoxide as a solvent, methanol as an etherification reagent and anhydrous potassium carbonate as alkali to react for 24 hours, reaction liquid is extracted by an organic solvent, washed by water, dried, concentrated to remove the solvent, and distilled to obtain solid 2-methyl-3-nitrobenzyl ether;
the mass ratio of dimethyl sulfoxide to 3-fluoro-2-methyl nitrobenzene is 5-10, the molar ratio of methanol to 3-fluoro-2-methyl nitrobenzene is 3-3.5, and the molar ratio of anhydrous potassium carbonate to 3-fluoro-2-methyl nitrobenzene is 2-2.5.
As a preferable technical scheme of the invention, the etherification reagent used in the step (A) is methanol.
As a preferred technical scheme of the invention, the organic solvent used in the first step is one or a combination of DMSO, DMAc and NMP.
As a preferable technical scheme of the invention, the alkali used in the first step is one or a combination of anhydrous potassium carbonate, anhydrous sodium carbonate and anhydrous potassium phosphate.
As a preferred technical scheme of the invention, the organic solvent used in the first step comprises one or more of dichloromethane, methyl tertiary ether, ethyl acetate and petroleum ether.
The specific synthetic route is as follows:
Figure BDA0003788837040000021
compared with the prior art, the invention has the following beneficial effects:
the invention takes 3-fluoro-2-methyl nitrobenzene as raw material to obtain the target product through nucleophilic substitution reaction of methanol. The reaction raw materials are easy to obtain, the route is short, and the yield is high.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention.
Wherein like reference numerals refer to like parts throughout.
In addition, if a detailed description of known technologies is not necessary to illustrate the features of the present invention, it is omitted. It should be noted that as used in the following description, the terms "front," "back," "left," "right," "upper" and "lower" refer to directions in the drawings, and the terms "inner" and "outer" refer to directions toward and away from, respectively, the geometric center of a particular component.
In the drawings:
FIG. 1 is a reaction diagram of the present invention;
fig. 2 is a graph of peak results.
Detailed Description
The preferred embodiments of the present invention will be described in conjunction with the accompanying drawings, and it will be understood that they are described herein for the purpose of illustration and explanation and not limitation.
Example 1
The invention provides a using method of a preparation method of 2-methyl-3-nitrobenzyl ether, which comprises the following steps:
under the protection of argon, 600ml of DMSO, 40g of 3-fluoro-2-methyl nitrobenzene, 60g of methanol and 120g of anhydrous potassium carbonate are added into a 1L three-necked bottle, the system is heated to 120 ℃ and is kept warm for 24h, 500ml of water is added to quench the reaction, 500ml of dichloromethane is used for extraction, the saturated saline solution is washed with water, and the anhydrous sodium sulfate is dried, concentrated and distilled to obtain 22g of white solid (GC = 98.4%).
Example 2
Synthesis of 2-methyl-3-nitrobenzyl ether:
under the protection of argon, 6L of tetrahydrofuran, 400g of 3-fluoro-2-methyl nitrobenzene, 60g of methanol and 120g of anhydrous potassium carbonate are added into a 10L three-necked bottle, the mixture is kept warm for 24h, 1L of quenching reaction is added, 5L of dichloromethane is used for extraction, saturated saline is washed, anhydrous sodium sulfate is added for drying and concentration, and distillation is carried out to obtain 240g of white solid (GC = 98.4%).
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art will understand that various changes, modifications and substitutions can be made without departing from the spirit and scope of the invention as defined by the appended claims. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (5)

1. A preparation method of 2-methyl-3-nitrobenzyl ether comprises the following specific steps:
the first step, the synthesis of 2-methyl-3-nitrobenzyl ether takes 3-fluoro-2-methyl nitrobenzene as a raw material, dimethyl sulfoxide as a solvent, methanol as an etherification reagent and anhydrous potassium carbonate as alkali, the reaction is carried out for 24 hours, reaction liquid is extracted by an organic solvent, washed by water, dried, concentrated to remove the solvent, and distilled to obtain solid 2-methyl-3-nitrobenzyl ether;
the mass ratio of dimethyl sulfoxide to 3-fluoro-2-methyl nitrobenzene is 5-10, the molar ratio of methanol to 3-fluoro-2-methyl nitrobenzene is 3-3.5, and the molar ratio of anhydrous potassium carbonate to 3-fluoro-2-methyl nitrobenzene is 2-2.5.
2. A process for the preparation of 2-methyl-3-nitrobenzyl ether according to claim 1 wherein the etherification reagent used in the first step is methanol.
3. The method for preparing 2-methyl-3-nitrobenzyl ether according to claim 1, wherein the organic solvent used in the first step is one or a combination of DMSO, DMAc and NMP.
4. The preparation method of 2-methyl-3-nitrobenzyl ether according to claim 1, wherein the base used in the first step is one or more of anhydrous potassium carbonate, anhydrous sodium carbonate and anhydrous potassium phosphate.
5. The preparation method of 2-methyl-3-nitrobenzyl ether according to claim 1, wherein the organic solvent used in the first step comprises one or more of dichloromethane, methyl tertiary ether, ethyl acetate and petroleum ether.
CN202210958403.1A 2022-08-09 2022-08-09 Preparation method of 2-methyl-3-nitrobenzyl ether Pending CN115260037A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210958403.1A CN115260037A (en) 2022-08-09 2022-08-09 Preparation method of 2-methyl-3-nitrobenzyl ether

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210958403.1A CN115260037A (en) 2022-08-09 2022-08-09 Preparation method of 2-methyl-3-nitrobenzyl ether

Publications (1)

Publication Number Publication Date
CN115260037A true CN115260037A (en) 2022-11-01

Family

ID=83751572

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210958403.1A Pending CN115260037A (en) 2022-08-09 2022-08-09 Preparation method of 2-methyl-3-nitrobenzyl ether

Country Status (1)

Country Link
CN (1) CN115260037A (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080227784A1 (en) * 2006-06-21 2008-09-18 Institute Of Medicinal Molecular Design. Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives
WO2008110863A1 (en) * 2007-03-15 2008-09-18 Glenmark Pharmaceuticals S.A. Indazole derivatives and their use as vanilloid receptor ligands
CN102320978A (en) * 2011-09-22 2012-01-18 江苏康恒化工有限公司 Preparation method of anhydrous system o-nitroanisole
CN104557557A (en) * 2013-10-09 2015-04-29 中国石油化工股份有限公司 Method for preparing nitroanisole from m-nitrochlorobenzene oil
CN104755465A (en) * 2012-08-24 2015-07-01 武田药品工业株式会社 Heterocycic compound
WO2020005935A1 (en) * 2018-06-25 2020-01-02 Kadmon Corporation, Llc Glucose uptake inhibitors
CN111646904A (en) * 2020-05-28 2020-09-11 浙江闰土研究院有限公司 Method for synthesizing p-nitroanisole
CN112552224A (en) * 2020-12-30 2021-03-26 爱斯特(成都)生物制药股份有限公司 Synthesis method of 4-hydroxyindole
WO2021087112A1 (en) * 2019-10-30 2021-05-06 Biogen Ma Inc. Condensed bi-heterocycles as inhibiting agents for bruton's tyrosine kinase

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080227784A1 (en) * 2006-06-21 2008-09-18 Institute Of Medicinal Molecular Design. Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives
WO2008110863A1 (en) * 2007-03-15 2008-09-18 Glenmark Pharmaceuticals S.A. Indazole derivatives and their use as vanilloid receptor ligands
CN102320978A (en) * 2011-09-22 2012-01-18 江苏康恒化工有限公司 Preparation method of anhydrous system o-nitroanisole
CN104755465A (en) * 2012-08-24 2015-07-01 武田药品工业株式会社 Heterocycic compound
CN104557557A (en) * 2013-10-09 2015-04-29 中国石油化工股份有限公司 Method for preparing nitroanisole from m-nitrochlorobenzene oil
WO2020005935A1 (en) * 2018-06-25 2020-01-02 Kadmon Corporation, Llc Glucose uptake inhibitors
WO2021087112A1 (en) * 2019-10-30 2021-05-06 Biogen Ma Inc. Condensed bi-heterocycles as inhibiting agents for bruton's tyrosine kinase
CN111646904A (en) * 2020-05-28 2020-09-11 浙江闰土研究院有限公司 Method for synthesizing p-nitroanisole
CN112552224A (en) * 2020-12-30 2021-03-26 爱斯特(成都)生物制药股份有限公司 Synthesis method of 4-hydroxyindole

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DEBASIS DAS ET AL.: "Design, synthesis of orally bioavailable novel anaplastic lymphoma kinase (ALK) inhibitor diphenylaminopyrimidine analogs and efficacy study on NCI-H2228 xenografts mice model", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》, vol. 29, pages 1515 *
JAVIER AJENJO ET AL.: "Synthesis and nucleophilic aromatic substitution of 3-fluoro-5- nitro-1-(pentafluorosulfanyl)benzene", 《BEILSTEIN J. ORG. CHEM.》, vol. 12, pages 192 - 197 *
MARYANNA E. LANNING ET AL.: "Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2- naphthoates as selective inhibitors of the Mcl-1 oncoprotein", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》, vol. 113, pages 273 - 292, XP029475862, DOI: 10.1016/j.ejmech.2016.02.006 *
THOMAS H. MARSILJE ET AL.: "Synthesis, Structure−Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5‑Chloro‑N2‑(2-isopropoxy-5-methyl-4-(piperidin-4- yl)phenyl)‑N4‑(2-(isopropylsulfonyl)phenyl)pyrimidine-2, 4-diamine (LDK378) Currently in Phase 1 and Phase 2", 《J. MED. CHEM.》, vol. 56, pages 5675, XP055145299, DOI: 10.1021/jm400402q *

Similar Documents

Publication Publication Date Title
CN108997520B (en) Norbornene derivative homopolymer containing heterosaccharide unit and synthesis method thereof
KR100664969B1 (en) A new preparing method of methoxypolyethyleneglycol and its derivatives
CN105693470A (en) Continuous 3-methyl-3-buten-1-ol production method
CN112830907A (en) Method for preparing 5-hydroxymethylfurfural
CN108689866B (en) Synthesis method of (R) -3-aminobutanol
CN110156659B (en) Preparation method of polyfluoro-substituted 3-hydroxyl oxindole compound
CN114957193A (en) Method for green synthesis of vinylene carbonate
CN113831318A (en) Synthetic method of piperonylethylamine
CN115260037A (en) Preparation method of 2-methyl-3-nitrobenzyl ether
CN108276461B (en) Cheap synthesis method of ethyl vanillin- β -D-glucopyranoside
CN114907197B (en) Preparation method of biaziridine-based photocrosslinking probe intermediate and derivative
CN109535120A (en) The preparation method of 7- substitution -3,4,4,7- tetrahydro cyclobutane and cumarin -5- ketone
CN114835664A (en) Novel trans-styryl benzofuranone compound and efficient synthesis method thereof
CN112679512B (en) Trabectedin intermediate and preparation method thereof
CN102584765B (en) Synthetic method of liquid phase combination of hydroxyisoflavone compound
CN113999239B (en) Method for synthesizing diaza-bridge compound
KR20170024896A (en) Method of Producing Anhydrosugar Alcohols by Two-Step Hydrothermal Reaction
CN109369357B (en) Method for preparing symmetrical diaryl ketone by catalytic oxidation carbonylation
CN105017109A (en) Method for compounding sulphone by directly conducting sulfonylation on alcohol
CN108997454B (en) Chemical synthesis method of beta-arbutin
CN111499569B (en) Method for simultaneously synthesizing 5-bromo-2-phenylpyridine and 2- (4-bromophenyl) pyridine in one step without metal catalysis
CN108047285B (en) Cheap synthesis method of ortho-ester-substituted glucose phenolic glycoside compound
CN109053463B (en) Method for converting diaryl ether into N-cyclohexyl aniline compound
CN115521282B (en) Synthesis process of coumarin compound E-Suberenol
CN103333110A (en) Production method of medicinal laurocapram

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination